Norihiro Imai

1.2k total citations
71 papers, 692 citations indexed

About

Norihiro Imai is a scholar working on Hepatology, Epidemiology and Physiology. According to data from OpenAlex, Norihiro Imai has authored 71 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 38 papers in Epidemiology and 15 papers in Physiology. Recurrent topics in Norihiro Imai's work include Liver Disease Diagnosis and Treatment (34 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Liver Disease and Transplantation (17 papers). Norihiro Imai is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Liver Disease and Transplantation (17 papers). Norihiro Imai collaborates with scholars based in Japan, United States and China. Norihiro Imai's co-authors include Fumitaka Suzuki, Yoshiyuki Suzuki, Yusuke Kawamura, Tetsuya Hosaka, Norio Akuta, Hitomi Sezaki, Hiromitsu Kumada, Yasuji Arase, Masahiro Kobayashi and Yuya Seko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Norihiro Imai

65 papers receiving 680 citations

Peers

Norihiro Imai
Norihiro Imai
Citations per year, relative to Norihiro Imai Norihiro Imai (= 1×) peers Kengo Kawai

Countries citing papers authored by Norihiro Imai

Since Specialization
Citations

This map shows the geographic impact of Norihiro Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihiro Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihiro Imai more than expected).

Fields of papers citing papers by Norihiro Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihiro Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihiro Imai. The network helps show where Norihiro Imai may publish in the future.

Co-authorship network of co-authors of Norihiro Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Norihiro Imai. A scholar is included among the top collaborators of Norihiro Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norihiro Imai. Norihiro Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yamamoto, Takafumi, Takanori Ito, Kazuyuki Mizuno, et al.. (2025). Steroid initiation dose and duration of steroid reduction for immune checkpoint inhibitor‐induced liver injury. Hepatology Research. 55(7). 977–985. 1 indexed citations
3.
Yamamoto, Kenta, Takashi Honda, Shinya Yokoyama, et al.. (2024). Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers. 16(9). 1675–1675. 2 indexed citations
4.
Yokoyama, Shinya, Takashi Honda, Yoji Ishizu, et al.. (2024). Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center. Clinical Nutrition. 43(6). 1425–1432. 6 indexed citations
5.
Ito, Takanori, Shinya Yokoyama, Kenta Yamamoto, et al.. (2024). Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Digestive Diseases. 25(11-12). 685–693. 2 indexed citations
6.
Yamamoto, Kenta, Takashi Honda, Shinya Yokoyama, et al.. (2024). Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease. Microorganisms. 12(3). 610–610. 5 indexed citations
7.
8.
Imai, Norihiro, Yuki Ohsaki, Jinglei Cheng, et al.. (2023). Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases. Scientific Reports. 13(1). 6851–6851. 8 indexed citations
10.
Mizuno, Kazuyuki, Norihiro Imai, Takafumi Yamamoto, et al.. (2023). Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma. Cancers. 15(10). 2853–2853. 5 indexed citations
11.
Honda, Takashi, Shinya Yokoyama, Kenta Yamamoto, et al.. (2023). Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet. Nutrients. 15(6). 1473–1473. 6 indexed citations
12.
Yamamoto, Takafumi, Takanori Ito, Masatoshi Ishigami, et al.. (2022). Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury. Journal of Gastroenterology and Hepatology. 38(2). 251–258. 8 indexed citations
13.
Ishizu, Yoji, Yukio Ando, Shinya Yokoyama, et al.. (2022). An improved method to assess skeletal muscle mass in patients with liver cirrhosis based on computed tomography images. Hepatology Research. 52(11). 937–946. 5 indexed citations
14.
Yamamoto, Kenta, Takashi Honda, Takanori Ito, et al.. (2022). Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma. Digestive Diseases. 41(1). 138–147. 7 indexed citations
15.
Yamamoto, Kenta, Yoji Ishizu, Takashi Honda, et al.. (2022). Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease. Scientific Reports. 12(1). 3674–3674. 22 indexed citations
16.
Yokoyama, Shinya, Yoji Ishizu, Takashi Honda, et al.. (2021). Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis. Hepatology Research. 52(2). 199–209. 3 indexed citations
17.
Imai, Norihiro, C. Denise Okafor, Puneet Juneja, et al.. (2020). Allosteric regulation of thioesterase superfamily member 1 by lipid sensor domain binding fatty acids and lysophosphatidylcholine. Proceedings of the National Academy of Sciences. 117(36). 22080–22089. 15 indexed citations
18.
Imai, Norihiro, Kenji Ikeda, Yuya Seko, et al.. (2011). [Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure].. PubMed. 108(11). 1872–8. 2 indexed citations
19.
Imai, Norihiro, Kenji Ikeda, Yuya Seko, et al.. (2010). Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and Child-Pugh B liver cirrhosis. Kanzo. 51(12). 758–760. 1 indexed citations
20.
Imai, Norihiro, et al.. (2002). An Experiment in the Design and Development of a Multimedia Processor for Mobile Computing. 102(402). 13–18. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026